In positive early data from the RCT, sacubitril/valsartan given over 24 weeks reduced signs of heart damage in cancer ...

One is an siRNA biologic, the other an oral agent, but both lowered Lp(a) levels by 80% or more in ASCVD patients.

A mixed bag of counterintuitive results hinders trial interpretation, but experts still see actionable results.

A nasal spray would be a workaround for drug resistance seen with oral diuretics, with the potential to reduce hospital ...

Left atrial appendage occlusion (LAAO) appears to be a viable alternative to oral anticoagulation for stroke prevention in select patients undergoing catheter ablation for atrial fibrillation (AF), ...